首頁 > 市場調查報告書 > 醫療設備

醫學影像診斷藥物遞輸設備電子醫療設備內視鏡檢查設備

市場調查報告書

商品編碼

1442904

智慧藥丸 - 全球市場考量、競爭狀況、市場預測 (2030)

Smart Pills - Market Insights, Competitive Landscape, and Market Forecast - 2030

出版日期: 2024年03月01日 | 出版商:

DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

簡介目錄圖表

預計2024-2030年期間，全球智慧藥丸市場規模將以11.34%的複合年增長率大幅成長。多種因素推動了對智慧藥丸的需求，其中最重要的是人口老化的增加以及癌症和糖尿病等與生活方式相關的疾病發生率的上升。這些人口結構的變化迫切需要先進的醫療解決方案，並推動了智慧藥丸的採用。

此外，市場預計將受益於研發活動的增加以及用於智慧藥丸創新的資金的增加。微型相機整合、小型化和先進微處理器的普及等技術進步對於擴大整體市場格局至關重要。這些技術進步提高了智慧藥丸的診斷和治療能力，使其成為現代醫學的重要工具。

對微創手術的需求快速增長以及對患者便利性的重視進一步加速了市場的成長。這些因素的結合證明了智慧藥丸的變革潛力，不僅可以推動市場向前發展，而且可以徹底改變醫療診斷和治療方法。

此外，由於新產品的推出和批准的大量湧入，預計智慧藥丸市場將持續成長。這種動態格局的特點是越來越注重透過創新解決方案解決未滿足的醫療需求，從而推動市場擴張。2024 年至 2030 年的預測期間將見證一個強大的智慧藥丸產品生態系統，預計將為醫療保健產業這一變革性細分市場的整體成長和發展做出重大貢獻。

智慧藥丸市場動態

全球各種胃腸道疾病的迅速增加預計將顯著提振智慧藥丸市場。European Federation of Crohn's and Ulcerative Colitis Associations（EFCCA）的最新數據顯示，全球有多達 1,000 萬人患有發炎性腸道疾病 (IBD)。此外，National Institute for Health and Care Excellence稱，在英國，腸躁症 (IBS) 通常發病於 20 歲至 30 歲之間，一般人群中每年的盛行率為 10% 至 20%。情況的嚴重性。令人擔憂的是，許多人即使出現腸躁症症狀也不就醫，而且據信真實盛行率可能更高。

根據 GLOBOCAN (2021) 的數據，大腸直腸癌是消化系統中的棘手問題，2020 年全球新病例為 1,931,590 例。全球胃腸道疾病的迅速增加表明對智慧藥丸的需求不斷增長，智慧藥丸在診斷和治療中發揮至關重要的作用。

患者對微創手術的偏好不斷增加，進一步推動了智慧藥丸市場的發展。智慧藥丸具有獨特的優勢，例如先進的膠囊內視鏡檢查、精確的藥物傳輸和無縫的遠端患者監測。這些特性有助於智慧藥丸在胃腸道疾病和癌症的治療範例中得到越來越多的採用。

產業進入者對研發 (R&D) 的大量投資以及聯盟和收購等策略舉措進一步推動了市場動態。一個著名的例子是 EtectRx 與 Pear Therapeutics 於 2021 年 1 月建立的合作關係。該合作夥伴關係旨在整合嵌入藥物和數位療法中的無線感測器，將藥物依從性數據與創新治療方法相結合。

總之，由於胃腸道疾病盛行率上升、患者轉向微創手術以及行業的策略性舉措，智慧藥丸市場預計將在 2024 年至 2030 年出現強勁增長。持續的技術進步以及研究和夥伴關係方面的協作努力證明了智慧藥丸在應對不斷變化的胃腸道醫學領域的變革潛力。

本報告提供了全球智慧藥丸市場的研究和分析，包括市場規模和預測、驅動因素和挑戰以及公司和產品概況。

Medtronic
Capso Vision Inc.
Olympus America
Hoya (Pentax Medical)
etectRx
Check-Cap
INTROMEDIC
HQ, Inc.
Koninklijke Philips N.V.
Novartis AG
BodyCAP
Medisafe
Otsuka America Pharmaceutical, Inc.
JINSHAN Science &Technology
Proteus Digital Health, Inc.
AnX Robotics.
Medimetrics S.A. de C.V.
BioCam
BDD Limited
RF Co., Ltd.

第8章 KOL觀點

第9章專案方法

第10章 DelveInsight服務內容

第 11 章關於 DelveInsight

第 12 章免責聲明，聯絡我們

簡介目錄圖表

Product Code: DIMDCL0690

Smart Pills Market By Product (Capsules And Software And Accessories), Application (Capsule Endoscopy [Small Bowel Video Capsule Endoscopy And Colon Capsule Endoscopy], Patient Monitoring, And Drug Delivery), Disease (Crohn's Disease, Small Bowel Tumors, Inherited Polyposis Syndromes, GI Bleeding, And Others), End-Users (Hospitals & Clinics, Diagnostic Centers, And Others), and geography is expected to grow at a steady CAGR forecast till 2030 owing to the increasing prevalence of gastrointestinal diseases and the increasing demand of minimally invasive approaches across the globe

The global smart pills market is poised for significant growth, projected to achieve a remarkable Compound Annual Growth Rate (CAGR) of 11.34% during the forecast period from 2024 to 2030. A confluence of factors propels the demand for smart pills, with a notable impact stemming from the rising geriatric population and the escalating incidence of lifestyle-related diseases such as cancer and diabetes. This demographic shift is creating a pressing need for advanced healthcare solutions, thereby fostering the adoption of smart pills.

Moreover, the market is set to benefit from heightened research and development endeavors, coupled with increased funding dedicated to smart pill innovation. Technological strides, including the integration of micro-cameras, miniaturization, and the widespread availability of advanced microprocessors, are pivotal in augmenting the overall market landscape. These technological enhancements enhance the diagnostic and therapeutic capabilities of smart pills, positioning them as vital tools in modern healthcare.

The surge in demand for minimally invasive procedures and a growing emphasis on patient convenience further amplify the market's trajectory. The convergence of these factors not only propels the market forward but also underscores the transformative potential of smart pills in revolutionizing medical diagnostics and treatment methodologies.

Furthermore, the smart pills market is poised for sustained growth due to an influx of new product launches and approvals. The dynamic landscape is characterized by an increasing focus on addressing unmet medical needs through innovative solutions, thereby driving the market's expansion. The forecast period from 2024 to 2030 is expected to witness a robust ecosystem of smart pill offerings, contributing significantly to the overall growth and development of this transformative segment within the healthcare industry.

Smart Pills Market Dynamics:

The burgeoning prevalence of diverse gastrointestinal diseases globally is poised to significantly boost the smart pills market. A compelling illustration is provided by recent data from the European Federation of Crohn's and Ulcerative Colitis Associations (EFCCA), revealing that a staggering 10 million individuals worldwide grapple with Inflammatory Bowel Disease (IBD). Furthermore, the National Institute for Health and Care Excellence underscores the gravity of the situation, reporting that Irritable Bowel Syndrome (IBS) typically emerges between ages 20 and 30 in the United Kingdom, with a prevalence of 10% to 20% in the general population annually. Alarmingly, it is believed that many with IBS symptoms forego medical consultation, indicating a potentially higher true prevalence.

Colorectal cancer, a formidable gastrointestinal challenge, saw 1,931,590 new global cases in 2020 according to GLOBOCAN 2021. This collective surge in gastrointestinal ailments globally underscores the escalating demand for smart pills, which play a pivotal role in both diagnosis and treatment.

The growing preference for minimally invasive procedures among patients propels the smart pills market further. Smart pills offer distinctive advantages such as advanced capsule endoscopy, precise drug delivery, and seamless remote patient monitoring. These attributes contribute to the increasing adoption of smart pills in the treatment paradigm for gastrointestinal diseases and cancer.

Market dynamics are further catalyzed by substantial investments in Research and Development (R&D) by industry players, coupled with strategic initiatives like partnerships and acquisitions. A noteworthy example is the collaboration between EtectRx and Pear Therapeutics in January 2021. This partnership aims to integrate wireless sensors embedded in medications with digital therapeutics, combining medication adherence data with innovative therapeutic approaches.

In conclusion, the confluence of rising gastrointestinal disease prevalence, the patient shift towards minimally invasive procedures, and strategic industry initiatives position the smart pills market for robust growth from 2024 to 2030. The continual advancements in technology and concerted efforts in research and partnerships underscore the transformative potential of smart pills in addressing the evolving landscape of gastrointestinal healthcare.

However, risks related to the smart pills, the high costs associated with the device, and others may restrict the growth of the overall smart pills market.

Smart Pills Market Segment Analysis:

Smart pills Market by Product (Capsules and Software and Accessories), Application (Capsule Endoscopy [Small Bowel Video Capsule Endoscopy and Colon Capsule Endoscopy], Patient Monitoring, and Drug Delivery), Disease (Crohn's Disease, Small Bowel Tumors, Inherited Polyposis Syndromes, GI Bleeding, and Others), End-Users (Hospitals & Clinics, Diagnostic Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

Within the application segment of the smart pills market, the small bowel video capsule endoscopy category is poised to capture a substantial revenue share in 2023, driven by its inherent advantages and diverse applications. Small bowel video capsule endoscopy is a non-invasive procedure employing a miniature wireless camera to capture images of the digestive tract, particularly the small intestine. This innovative approach involves the patient swallowing a capsule, akin to a large pill, housing a camera.

The miniature camera within the small bowel video capsule endoscopy system, encapsulated in a vitamin-sized pill, travels through the digestive tract, capturing thousands of images transmitted to a recorder worn on a belt around the patient's waist. Not only does this procedure offer a detailed view of the small intestine, but it also eliminates the need for invasive measures, aligning with the growing trend towards minimally invasive healthcare technologies.

Furthermore, ongoing advancements in small bowel video capsule endoscopes, particularly in batteries and onboard memory, contribute to their suitability for prolonged usage, enhancing diagnostic capabilities. The market benefits from the presence of technologically advanced devices designed for optimal visualization of the small intestine. For instance, CapsoCam Plus, a product by CapsoVision, stands out by providing a full 360º panoramic direct lateral view of the small bowel mucosa, thereby improving diagnostic accuracy.

The momentum in this segment is further fueled by a series of product launches, regulatory approvals, and strategic initiatives. A notable instance is Medtronic plc's PillCam Small Bowel 3 system, which received clearance from the United States Food and Drug Administration (FDA) in November 2021 for remote endoscopy procedures. The ingestible camera in this capsule facilitates comprehensive visualization of the small bowel, exemplifying the continuous innovation within the field.

In light of these factors, the small bowel video capsule endoscopy category is anticipated to experience substantial growth, contributing significantly to the overall expansion of the smart pills market throughout the forecast period. The convergence of technological advancements, non-invasiveness, and strategic industry moves positions this category as a key driver in shaping the future landscape of smart medical solutions.

North America is expected to dominate the overall Smart Pills Market:

In the year 2023, North America is anticipated to secure the leading share in the smart pills market, driven by several pivotal factors that underscore the region's prominence. The prevalence of chronic diseases, particularly gastrointestinal ailments and associated cancers, stands out as a key growth driver. This is substantiated by the International Foundation for Gastrointestinal Disorders (IFFGD) 2021 report, revealing that 25 to 45 million individuals in the United States were affected by irritable bowel syndrome during that year.

The region's receptiveness to technologically advanced solutions, aiming to streamline patient care, plays a crucial role. The widespread adoption of such solutions is facilitated by a large and discerning customer base, further complemented by the rapidly growing geriatric population. Regulatory approvals for innovative devices, coupled with heightened awareness regarding disease diagnosis through smart pill technology, further contribute to the region's prosperous outlook.

The International Foundation for Gastrointestinal Disorders (IFFGD) report highlights the escalating burden of Inflammatory Bowel Disease (IBD) in Canada, projecting an increase from 322,600 people affected in 2023 to 470,000 in 2035. This trend underscores the growing demand for smart pills for both diagnosis and treatment in response to the rising prevalence of gastrointestinal diseases.

Notably, the region benefits from the presence of key industry players, fostering a conducive environment for product development activities. Additionally, the United States Food and Drug Administration (FDA) has been instrumental in shaping the market trajectory by granting approvals for innovative technologies. An illustrative example is the FDA's clearance in December 2019 for etectRx's ID-CAP System - a pill embedded with sensors that wirelessly communicates with an external system, revolutionizing remote health monitoring without physical contact.

In light of these factors, the smart pills market in North America is poised for substantial growth during the forecast period from 2024 to 2030. The confluence of increasing disease prevalence, regulatory support, technological advancements, and a robust healthcare ecosystem positions the region as a pivotal player in driving the evolution of smart medical solutions.

Smart Pills Market Key Players:

Some of the key market players operating in the smart pills market include Medtronic, Capso Vision Inc., Olympus America, Hoya (Pentax Medical), etectRx, Check-Cap, INTROMEDIC, HQ, Inc., Koninklijke Philips N.V., Novartis AG, BodyCAP, Medisafe, Otsuka America Pharmaceutical, Inc., JINSHAN Science & Technology, Proteus Digital Health, Inc., AnX Robotics, Medimetrics S.A. de C.V., BioCam, BDD Limited, RF Co., Ltd., and others.

Recent Developmental Activities in the Smart Pills Market:

In February 2023, AnX Robotica Corp. (US) launched the NaviCam Small Bowel System in the US. The NaviCam SB System utilizes aspherical lens technology to reduce distortion and enhance the field of vision, a critical component in the diagnosis of small bowel disease.
In 2021, Check-Cap (Israel) expanded C-Scan's manufacturing capacity and on-premises production line, while also remedying technical issues from a single source supplier. The company significantly expanded its production line to support its US pivotal study.
In June 2020, AnX Robotica Corp. was granted by the FDA De-Novo classification for its NaviCam Magnetically Controlled Capsule Endoscopy (MCCE) System. It is the first-of-its-kind system that allows complete, real-time visualization of the stomach utilizing a pill-sized capsule containing a camera and is remote-controlled by the physician using proprietary magnetic technologies.
In December 2020, CapsoVision Inc., achieved the International Standard Organization (ISO) 27001 security certification. The scope of the certification includes CapsoVision's headquarters and the company's CapsoCloud software. This certification validates the company's long-term commitment to the protection of customer data.

Key Takeaways from the Smart Pills Market Report Study

Market size analysis for current smart pills market size (2023), and market forecast for 6 years (2024-2030)
Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
Key companies dominating the global smart pills market.
Various opportunities available for the other competitors in the smart pills market space.
What are the top-performing segments in 2023? How these segments will perform in 2030?
Which are the top-performing regions and countries in the current smart pills market scenario?
Which are the regions and countries where companies should have concentrated on opportunities for smart pills market growth in the coming future?

Target Audience who can be benefited from this Smart Pills Market Report Study

Smart pill product providers
Research organizations and consulting companies
Smart pills-related organizations, associations, forums, and other alliances
Government and corporate offices
Start-up companies, venture capitalists, and private equity firms
Distributors and Traders dealing in smart pills
Various End-users who want to know more about the smart pills market and the latest technological developments in the smart pills market.

Frequently Asked Questions for the Smart Pills Market:

1. What are smart pills?

Smart pills, also known as digital pills or ingestible sensors, are medical capsules or tablets that contain embedded sensors, cameras, or other monitoring devices. These technological components allow the smart pills to collect and transmit data about physiological conditions, medication adherence, and other relevant information from inside the human body. The primary purpose of smart pills is to enhance medical diagnostics, patient monitoring, and drug delivery. They are designed to provide healthcare professionals with real-time information about a patient's health status and response to medication.

2. What is the market for global smart pills?

The global smart pills market is poised for significant growth, projected to achieve a remarkable Compound Annual Growth Rate (CAGR) of 11.34% during the forecast period from 2024 to 2030.

3. What are the drivers for the global smart pills market?

The demand for smart pills is primarily being boosted by the increasing prevalence of increasing prevalence of chronic diseases, high demand for minimally invasive procedures, an increase in focus on patient convenience, technological development including miniaturization of integrated circuits, increasing product launches and approvals, and others thereby contributing to the overall growth of the smart pills market during the forecast period from 2024-2030.

4. Who are the key players operating in the global smart pills market?

5. Which region has the highest share in the smart pills market?

North America is expected to dominate the overall smart pills market during the forecast period from 2024-2030. Owing to factors such as the rising prevalence of chronic diseases and gastrointestinal diseases and related cancers, wide acceptance of technologically advanced solutions to make patient care hassle-free, a large pool of customers, a rapidly growing geriatric population, regulatory approval for new devices, and high awareness about the diagnosis of the disease using smart pill technology among others, the North America smart pills market is expected to growth in coming years.

1. Smart Pills Market Report Introduction

2. Smart Pills Market Executive Summary

2.1. Scope of the Study
2.2. Market at Glance
2.3. Competitive Assessment

3. Regulatory Analysis

3.1. The United States
3.2. Europe
3.3. Japan
3.4. China

4. Smart Pills Market Key Factors Analysis

4.1. Smart Pills Market Drivers
- 4.1.1. Increasing prevalence of gastrointestinal disorders
- 4.1.2. Surging Preference for minimally-invasive device
- 4.1.3. Technological advancements about smart pills
4.2. Smart Pills Market Restraints and Challenges
- 4.2.1. Risks related to the smart pills
- 4.2.2. High cost associated with the device
4.3. Smart Pills Market Opportunities
- 4.3.1. Growing demand for advanced drug delivery system
- 4.3.2. Increasing R&D investments and intensive product pipelines

5. Smart Pills Market Porter's Five Forces Analysis

5.1. Bargaining Power of Suppliers
5.2. Bargaining Power of Consumers
5.3. Threat of New Entrants
5.4. Threat of Substitutes
5.5. Competitive Rivalry

6. Smart Pills Market Layout

6.1. By Product
- 6.1.1. Capsules
- 6.1.2. Software and Accessories
6.2. By Application
- 6.2.1. Capsule Endoscopy
  - 6.2.1.1. Small Bowel Video Capsule Endoscopy
  - 6.2.1.2. Colon Capsule Endoscopy
- 6.2.2. Patient Monitoring
- 6.2.3. Drug Delivery
6.3. By Disease
- 6.3.1. Crohn's Disease
- 6.3.2. Small Bowel Tumors
- 6.3.3. Inherited Polyposis Syndromes
- 6.3.4. GI bleeding
- 6.3.5. Others
6.4. By End-Users
- 6.4.1. Hospitals & Clinics
- 6.4.2. Diagnostic Centers
- 6.4.3. Others
6.5. By Geography
- 6.5.1. North America
  - 6.5.1.1. United States Smart Pills Market Size in USD million (2021-2030)
  - 6.5.1.2. Canada Smart Pills Market Size in USD million (2021-2030)
  - 6.5.1.3. Mexico Smart Pills Market Size in USD million (2021-2030)
- 6.5.2. Europe
  - 6.5.2.1. France Smart Pills Market Size in USD million (2021-2030)
  - 6.5.2.2. Germany Smart Pills Market Size in USD million (2021-2030)
  - 6.5.2.3. United Kingdom Smart Pills Market Size in USD million (2021-2030)
  - 6.5.2.4. Italy Smart Pills Market Size in USD million (2021-2030)
  - 6.5.2.5. Spain Smart Pills Market Size in USD million (2021-2030)
  - 6.5.2.6. Rest of Europe Smart Pills Market Size in USD million (2021-2030)
- 6.5.3. Asia-Pacific
  - 6.5.3.1. China Smart Pills Market Size in USD million (2021-2030)
  - 6.5.3.2. Japan Smart Pills Market Size in USD million (2021-2030)
  - 6.5.3.3. India Smart Pills Market Size in USD million (2021-2030)
  - 6.5.3.4. Australia Smart Pills Market Size in USD million (2021-2030)
  - 6.5.3.5. South Korea Smart Pills Market Size in USD million (2021-2030)
  - 6.5.3.6. Rest of Asia-Pacific Smart Pills Market Size in USD million (2021-2030)
- 6.5.4. Rest of the World (RoW)
  - 6.5.4.1. Middle East Smart Pills Market Size in USD million (2021-2030)
  - 6.5.4.2. Africa Smart Pills Market Size in USD million (2021-2030)
  - 6.5.4.3. South America Smart Pills Market Size in USD million (2021-2030)

7. Smart Pills Market Company and Product Profiles

7.1. Medtronic
- 7.1.1. Company Overview
- 7.1.2. Company Snapshot
- 7.1.3. Financial Overview
- 7.1.4. Product Listing
- 7.1.5. Entropy
7.2. Capso Vision Inc.
- 7.2.1. Company Overview
- 7.2.2. Company Snapshot
- 7.2.3. Financial Overview
- 7.2.4. Product Listing
- 7.2.5. Entropy
7.3. Olympus America
- 7.3.1. Company Overview
- 7.3.2. Company Snapshot
- 7.3.3. Financial Overview
- 7.3.4. Product Listing
- 7.3.5. Entropy
7.4. Hoya (Pentax Medical)
- 7.4.1. Company Overview
- 7.4.2. Company Snapshot
- 7.4.3. Financial Overview
- 7.4.4. Product Listing
- 7.4.5. Entropy
7.5. etectRx
- 7.5.1. Company Overview
- 7.5.2. Company Snapshot
- 7.5.3. Financial Overview
- 7.5.4. Product Listing
- 7.5.5. Entropy
7.6. Check-Cap
- 7.6.1. Company Overview
- 7.6.2. Company Snapshot
- 7.6.3. Financial Overview
- 7.6.4. Product Listing
- 7.6.5. Entropy
7.7. INTROMEDIC
- 7.7.1. Company Overview
- 7.7.2. Company Snapshot
- 7.7.3. Financial Overview
- 7.7.4. Product Listing
- 7.7.5. Entropy
7.8. HQ, Inc.
- 7.8.1. Company Overview
- 7.8.2. Company Snapshot
- 7.8.3. Financial Overview
- 7.8.4. Product Listing
- 7.8.5. Entropy
7.9. Koninklijke Philips N.V.
- 7.9.1. Company Overview
- 7.9.2. Company Snapshot
- 7.9.3. Financial Overview
- 7.9.4. Product Listing
- 7.9.5. Entropy
7.10. Novartis AG
- 7.10.1. Company Overview
- 7.10.2. Company Snapshot
- 7.10.3. Financial Overview
- 7.10.4. Product Listing
- 7.10.5. Entropy
7.11. BodyCAP
- 7.11.1. Company Overview
- 7.11.2. Company Snapshot
- 7.11.3. Financial Overview
- 7.11.4. Product Listing
- 7.11.5. Entropy
7.12. Medisafe
- 7.12.1. Company Overview
- 7.12.2. Company Snapshot
- 7.12.3. Financial Overview
- 7.12.4. Product Listing
- 7.12.5. Entropy
7.13. Otsuka America Pharmaceutical, Inc.
- 7.13.1. Company Overview
- 7.13.2. Company Snapshot
- 7.13.3. Financial Overview
- 7.13.4. Product Listing
- 7.13.5. Entropy
7.14. JINSHAN Science & Technology
- 7.14.1. Company Overview
- 7.14.2. Company Snapshot
- 7.14.3. Financial Overview
- 7.14.4. Product Listing
- 7.14.5. Entropy
7.15. Proteus Digital Health, Inc.
- 7.15.1. Company Overview
- 7.15.2. Company Snapshot
- 7.15.3. Financial Overview
- 7.15.4. Product Listing
- 7.15.5. Entropy
7.16. AnX Robotics.
- 7.16.1. Company Overview
- 7.16.2. Company Snapshot
- 7.16.3. Financial Overview
- 7.16.4. Product Listing
- 7.16.5. Entropy
7.17. Medimetrics S.A. de C.V.
- 7.17.1. Company Overview
- 7.17.2. Company Snapshot
- 7.17.3. Financial Overview
- 7.17.4. Product Listing
- 7.17.5. Entropy
7.18. BioCam
- 7.18.1. Company Overview
- 7.18.2. Company Snapshot
- 7.18.3. Financial Overview
- 7.18.4. Product Listing
- 7.18.5. Entropy
7.19. BDD Limited
- 7.19.1. Company Overview
- 7.19.2. Company Snapshot
- 7.19.3. Financial Overview
- 7.19.4. Product Listing
- 7.19.5. Entropy
7.20. RF Co., Ltd.
- 7.20.1. Company Overview
- 7.20.2. Company Snapshot
- 7.20.3. Financial Overview
- 7.20.4. Product Listing
- 7.20.5. Entropy